On a prime role for newly synthesized dopamine in striatal function

Area of Science:

• Neuropharmacology
• Dopaminergic System Research

Background:

• Neuroleptic drugs like haloperidol induce catalepsy, a motor disturbance.
• Tyrosine hydroxylase inhibitors, such as alpha-methyltyrosine (alphaMT), affect dopamine synthesis.

Purpose of the Study:

• To investigate the interaction between alphaMT and haloperidol on catalepsy in rats.
• To elucidate the role of newly synthesized dopamine in haloperidol-induced catalepsy.

Main Methods:

• Rats were administered alphaMT (10 or 250 mg/kg) or haloperidol (0.25 mg/kg) alone or in combination.
• Catalepsy was assessed, and striatal dopamine (DA) and homovanillic acid levels were measured.

Main Results:

• Haloperidol alone induced mild catalepsy; alphaMT alone induced none.
• The combination of haloperidol and alphaMT rapidly produced strong catalepsy.
• Striatal DA stores were minimally depleted, but homovanillic acid levels were reduced by alphaMT pretreatment.

Conclusions:

• Potentiation of haloperidol-induced catalepsy by alphaMT is linked to the lack of newly synthesized DA, not depleted main DA stores.
• Newly synthesized DA plays a more significant role in striatal function than DA from the main storage pool.